SLC5A2 and metabolic syndrome: When renal cells are exposed to nutrient excess (as in T2DM or human metabolic syndrome), SGLT2 inhibitor effects go beyond their haemodynamic and tubular transport effects to include beneficial actions on autophagy and mitophagy (see Packer, 2022 and above), phenomena explained below.